EVT-101

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameEVT-101
Drug Alias NameENS-101EVT-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche LtdEvotec
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche LtdJanssen Research & Development Llc
Active IndicationsN/A
Inactive IndicationsDepression

Other Information

ATC CodeN/A
Related LinksN/A